FibroBiologics Stock Forecast

FBLG's stock price has decreased by -94.17% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, FibroBiologics stock has a consensus rating of "Buy" and an average price target of $13.5. The average 1-year stock price forecast is 1,138.53% higher than the current stock price, while the lowest is $8.00 (+633.94%) and the highest is $19 (+1,643.12%).

Price Target: $13.5 (+1,138.53%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$13.5	$13.5	$19
Change	+633.94%	+1138.5%	+1138.5%	+1643.1%

* Price targets were last updated on Apr 16, 2026.

Analyst Ratings

The average analyst rating for FibroBiologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	2	2	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 4, 2026
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $4 → $8	Strong Buy	Maintains	$4 → $8	+633.94%	Apr 16, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 26, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $140	Strong Buy	Maintains	$140	+12,744.04%	Mar 12, 2026
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $100 → $80	Strong Buy	Maintains	$100 → $80	+7,239.45%	Feb 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.95

from -8.35

EPS Next Year

-1.04

from -1.95

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.62	-3.63	-13.50	-6.79	-8.35	-1.95	-1.04
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.04	-0.59
Avg	-1.95	-1.04
Low	-2.78	-1.45

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.